INGR · Ingredion Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $7.22B | $7.43B | $8.16B | $7.95B | $6.89B | $5.99B |
| Cost of Revenue | $5.39B | $5.64B | $6.41B | $6.45B | $5.56B | $4.71B |
| Gross Profit | $1.83B | $1.79B | $1.75B | $1.49B | $1.33B | $1.27B |
| R&D | $71.00M | $67.00M | $63.00M | $52.00M | $43.00M | - |
| SG&A | - | - | - | - | - | - |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $222.00M | $214.00M | $219.00M | $215.00M | $220.00M | $213.00M |
| Operating Income | $1.02B | $883.00M | $957.00M | $762.00M | $310.00M | $582.00M |
| Interest Expense | - | - | - | - | - | - |
| Income Tax | $238.00M | $277.00M | $188.00M | $166.00M | $123.00M | $152.00M |
| Net Income | $729.00M | $647.00M | $643.00M | $492.00M | $117.00M | $348.00M |
| EPS - Basic | $11.36 | $9.88 | $9.74 | $7.43 | $1.74 | $5.18 |
| EPS - Diluted | $11.18 | $9.71 | $9.60 | $7.34 | $1.73 | $5.15 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.03B | $997.00M | $401.00M | $236.00M | $328.00M | $665.00M |
| Accounts Receivable | $1.19B | $1.09B | $1.28B | $1.41B | $1.01B | $1.01B |
| Inventory | $1.23B | $1.19B | $1.45B | $1.60B | $1.17B | $917.00M |
| Accounts Payable | $693.00M | $604.00M | $778.00M | $873.00M | $774.00M | $599.00M |
| Current Assets | $3.50B | $3.35B | $3.40B | $3.31B | $2.70B | $2.65B |
| Total Assets | $7.90B | $7.44B | $7.64B | $7.56B | $7.00B | $6.86B |
| Current Liabilities | $1.32B | $1.28B | $1.77B | $1.88B | $1.51B | $1.46B |
| Long-term Debt | $1.74B | $1.79B | $1.74B | $1.94B | $1.74B | $1.75B |
| Total Liabilities | $3.53B | $3.55B | $3.99B | $4.30B | $3.77B | $3.79B |
| Stockholders' Equity | $4.27B | $3.80B | $3.54B | $3.15B | $3.10B | $2.95B |
| Retained Earnings | $5.61B | $5.09B | $4.65B | $4.21B | $3.90B | $3.96B |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $944.00M | $1.44B | $1.06B | $152.00M | $392.00M | $829.00M |
| Investing Cash Flow | ($444.00M) | ($47.00M) | ($329.00M) | ($320.00M) | ($335.00M) | ($571.00M) |
| Financing Cash Flow | ($491.00M) | ($765.00M) | ($569.00M) | $103.00M | ($373.00M) | $143.00M |
| CapEx | $433.00M | $301.00M | $316.00M | $300.00M | $300.00M | $340.00M |
| Free Cash Flow | $511.00M | $1.14B | $741.00M | ($148.00M) | $92.00M | $489.00M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 25.3% | 24.1% | 21.4% | 18.8% | 19.3% | 21.2% |
| Operating margin | 14.1% | 11.9% | 11.7% | 9.6% | 4.5% | 9.7% |
| EBITDA margin | 17.1% | 14.8% | 14.4% | 12.3% | 7.7% | 13.3% |
| Net margin | 10.1% | 8.7% | 7.9% | 6.2% | 1.7% | 5.8% |
| Free cash flow margin | 7.1% | 15.3% | 9.1% | -1.9% | 1.3% | 8.2% |
| FCF / Net income | 0.70 | 1.75 | 1.15 | -0.30 | 0.79 | 1.41 |
| R&D / Revenue | 1.0% | 0.9% | 0.8% | 0.7% | 0.6% | - |
| SG&A / Revenue | - | - | - | - | - | - |
| Effective tax rate | 24.6% | 30.0% | 22.6% | 25.2% | 51.2% | 30.4% |
| Return on assets | 9.2% | 8.7% | 8.4% | 6.5% | 1.7% | 5.1% |
| Return on equity | 17.1% | 17.0% | 18.2% | 15.6% | 3.8% | 11.8% |
| Return on invested capital | 12.7% | 11.1% | 14.0% | 11.2% | 3.2% | 8.6% |
| Liquidity | ||||||
| Current ratio | 2.66 | 2.62 | 1.92 | 1.76 | 1.78 | 1.82 |
| Quick ratio | 1.73 | 1.69 | 1.10 | 0.91 | 1.01 | 1.19 |
| Cash ratio | 0.78 | 0.78 | 0.23 | 0.13 | 0.22 | 0.46 |
| Leverage | ||||||
| Debt / Equity | 0.41 | 0.47 | 0.49 | 0.62 | 0.56 | 0.59 |
| Debt / Assets | 0.22 | 0.24 | 0.23 | 0.26 | 0.25 | 0.25 |
| Debt / EBITDA | 1.41 | 1.63 | 1.48 | 1.99 | 3.28 | 2.20 |
| Interest coverage | - | - | - | - | - | - |
| Equity multiplier | 1.85 | 1.96 | 2.16 | 2.40 | 2.26 | 2.32 |
| Liabilities / Assets | 0.45 | 0.48 | 0.52 | 0.57 | 0.54 | 0.55 |
| Efficiency | ||||||
| Asset turnover | 0.91 | 1.00 | 1.07 | 1.05 | 0.98 | 0.87 |
| Inventory turnover | 4.39 | 4.75 | 4.42 | 4.04 | 4.75 | 5.14 |
| Days sales outstanding | 60d | 54d | 57d | 65d | 54d | 62d |
| Days inventory outstanding | 83d | 77d | 83d | 90d | 77d | 71d |
| Days payable outstanding | 47d | 39d | 44d | 49d | 51d | 46d |
| Cash conversion cycle | 96d | 91d | 95d | 106d | 80d | 86d |
| Valuation | ||||||
| P / E | 9.9x | 14.2x | 11.3x | 13.3x | 55.9x | 15.3x |
| P / B | 1.7x | 2.4x | 2.1x | 2.1x | 2.1x | 1.8x |
| P / S | 1.0x | 1.2x | 0.9x | 0.8x | 1.0x | 0.9x |
| EV / EBITDA | 6.4x | 9.1x | 7.3x | 8.5x | 15.0x | 8.1x |
| Growth | ||||||
| Revenue growth (YoY) | -2.8% | -8.9% | 2.7% | 15.3% | 15.1% | -3.6% |
| Revenue CAGR (3y) | -3.1% | 2.5% | 10.9% | 8.6% | 6.5% | - |
| Revenue CAGR (5y) | 3.8% | 3.7% | 7.4% | - | - | - |
| Gross profit growth (YoY) | 2.1% | 2.4% | 17.1% | 12.2% | 4.6% | -3.0% |
| Operating income growth (YoY) | 15.1% | -7.7% | 25.6% | 145.8% | -46.7% | -12.3% |
| Net income growth (YoY) | 12.7% | 0.6% | 30.7% | 320.5% | -66.4% | -15.7% |
| EPS growth (YoY) | 15.1% | 1.1% | 30.8% | 324.3% | -66.4% | -16.0% |
| EPS CAGR (3y) | 15.1% | 77.7% | 23.1% | 6.2% | -34.5% | -10.0% |
| EPS CAGR (5y) | 16.8% | 9.6% | 9.2% | 0.8% | -23.4% | -1.3% |
| FCF growth (YoY) | -55.0% | 53.2% | - | - | -81.2% | 38.9% |
| FCF CAGR (5y) | 0.9% | 26.4% | 16.0% | - | -28.3% | 3.8% |
| Book value growth (YoY) | 12.4% | 7.5% | 12.4% | 1.5% | 5.0% | 8.5% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$6.94B totalTexture And Healthful Solutions Segment$2.43B · 35.0%
Food And Industrial Ingredients LATAMSegment$2.39B · 34.5%
Food And Industrial Ingredients U.S.Canada Segment$2.12B · 30.6%
Geographic
$7.22B totalUS$2.81B · 39.0%
MX$1.39B · 19.3%
Other Countries$982.00M · 13.6%
BR$572.00M · 7.9%
CA$495.00M · 6.9%
DE$384.00M · 5.3%
CO$324.00M · 4.5%
TH$255.00M · 3.5%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
2.62
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
8/9
Strong
- ✓Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✓Current ratio improved
- ✓No share dilution
- ✓Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Grain Mill Products
Comparing Ingredion Inc against the 5 most active filers in the same SIC group.
Dividends
$3.26/share trailing 12 months · +2.5% YoY
| Ex-date | Per share |
|---|---|
| Apr 1, 2026 | $0.8200 |
| Jan 2, 2026 | $0.8200 |
| Oct 1, 2025 | $0.8200 |
| Jul 1, 2025 | $0.8000 |
| Apr 1, 2025 | $0.8000 |
| Jan 2, 2025 | $0.8000 |
| Oct 1, 2024 | $0.8000 |
| Jul 1, 2024 | $0.7800 |
| Mar 28, 2024 | $0.7800 |
| Dec 29, 2023 | $0.7800 |
| Sep 29, 2023 | $0.7800 |
| Jun 30, 2023 | $0.7100 |
| Mar 31, 2023 | $0.7100 |
| Dec 29, 2022 | $0.7100 |
| Oct 5, 2022 | $0.7100 |
| Jun 30, 2022 | $0.6500 |
| Mar 31, 2022 | $0.6500 |
| Dec 31, 2021 | $0.6500 |
| Oct 1, 2021 | $0.6500 |
| Jun 30, 2021 | $0.6400 |
| Mar 31, 2021 | $0.6400 |
| Dec 31, 2020 | $0.6400 |
| Sep 30, 2020 | $0.6400 |
| Jun 30, 2020 | $0.6300 |